Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122726) titled 'Intrathecal Morphine for Pain Relief and Recovery After Uterine Artery Embolization' on April 16.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Guangdong Second Provincial General Hospital (Guangdong Provincial Emergency Hospital)

Condition: Uterine fibroids and adenomyosis

Intervention: Intrathecal Placebo + Standard Postoperative Care:Intrathecal Placebo

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: 2026-04-16

Target Sample Size: Intrathecal Placebo + Standard Postoperative Care:60;Intrathecal Morphine + Standard Postoperative Care:60;

Countries ...